Product Information

BLISOVI 24 FE TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.2034 per EA under NDC 68180086473. Its NADAC has been published 335 times since Jan 29, 2020.

BLISOVI 24 FE TABLET

norethindrone acetate and ethinyl estradiol
$0.2034per EA

NDC

68180086473

Classification

Generic

Dosage Form

KIT

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA091398

On Market Since

11/7/2019

Price Statistics

The NADAC for BLISOVI 24 FE TABLET has been published 335 times since Jan 29, 2020, and over the history we have for it it has declined 80.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2034 per EA
All-time high$1.0894 (Jan 13, 2021)
All-time low$0.1894 (Jul 17, 2024)
52-week high$0.2235
52-week low$0.2034
Median price$0.3713
Average price$0.5154
Largest weekly change+33.9% (Aug 21, 2024)
Weeks tracked335
Tracking sinceJan 29, 2020

Price History

1W

0.0%

1M

-3.2%

3M

-0.1%

6M

-8.0%

1Y

-9.0%

3Y

-39.8%

5Y

-77.9%

All

-80.0%

Generic Alternatives

The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 36% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of BLISOVI 24 FE TABLET?

The current National Average Drug Acquisition Cost (NADAC) for BLISOVI 24 FE TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.2034 per EA (NDC 68180086473), effective Jun 24, 2026.

How has the price of BLISOVI 24 FE TABLET changed over time?

Over the history we have for it, the NADAC for BLISOVI 24 FE TABLET has declined 80.0%. It has been tracked across 335 weekly CMS publications since Jan 29, 2020.

What are the highest and lowest recorded NADAC prices for BLISOVI 24 FE TABLET?

Since Jan 29, 2020, the NADAC for BLISOVI 24 FE TABLET has ranged from a low of $0.1894 (Jul 17, 2024) to a high of $1.0894 (Jan 13, 2021), with a median of $0.3713 per EA.

Are there cheaper alternatives to BLISOVI 24 FE TABLET?

Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, BLISOVI FE 1-20 TABLET, is $0.1311 per EA — about 36% below BLISOVI 24 FE TABLET.

Who manufactures BLISOVI 24 FE TABLET?

BLISOVI 24 FE TABLET (NDC 68180086473) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.

Related Drugs

Same classification

No related drugs found.